AptarGroup Inc. Unveils Presentation Highlighting Global Leadership in Drug and Consumer Product Technologies

Reuters

2025/06/05

AptarGroup Inc. Unveils Presentation Highlighting Global Leadership in Drug and Consumer Product Technologies

AptarGroup Inc. recently participated in the Jefferies Global Healthcare Conference, where CEO Stephan Tanda, CFO Vanessa Kanu, and SVP of Investor Relations & Communications Mary Skafidas presented insights into the company's operations. AptarGroup is a global leader in drug and consumer product dosing, dispensing, and protection technologies, with significant contributions from its Pharma and Beauty segments, which account for 46% and 34% of total reported sales in 2024, respectively. The company's proprietary drug delivery systems provide a competitive advantage, supported by a robust innovation pipeline and a portfolio of over 7,000 active and pending patents. AptarGroup's global presence is bolstered by over 13,000 employees across 20 countries and a diverse customer base of over 5,000 global clients. You can access the full presentation through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AptarGroup Inc. published the original content used to generate this news brief on June 04, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎国际,美股交易,港股交易,交易美股,股票信息,股价,美股行情,美股打新,港股打新,IPO打新,购买美股,全球投资","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2541179093"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2541179093\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2541179093?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-05 02:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2541179093","market":"nz","top_or_hot":-1,"title":"AptarGroup Inc. Unveils Presentation Highlighting Global Leadership in Drug and Consumer Product Technologies","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      AptarGroup Inc. Unveils Presentation Highlighting Global Leadership in Drug and Consumer Product Technologies\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        AptarGroup Inc. recently participated in the Jefferies Global Healthcare Conference, where CEO Stephan Tanda, CFO Vanessa Kanu, and SVP of Investor Relations &amp; Communications Mary Skafidas presented insights into the company's operations. AptarGroup is a global leader in drug and consumer product dosing, dispensing, and protection technologies, with significant contributions from its Pharma and Beauty segments, which account for 46% and 34% of total reported sales in 2024, respectively. The company's proprietary drug delivery systems provide a competitive advantage, supported by a robust innovation pipeline and a portfolio of over 7,000 active and pending patents. AptarGroup's global presence is bolstered by over 13,000 employees across 20 countries and a diverse customer base of over 5,000 global clients. You can access the full presentation through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AptarGroup Inc. published the original content used to generate this news brief on June 04, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AptarGroup Inc. Unveils Presentation Highlighting Global Leadership in Drug and Consumer Product Technologies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAptarGroup Inc. Unveils Presentation Highlighting Global Leadership in Drug and Consumer Product Technologies\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-05 02:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      AptarGroup Inc. Unveils Presentation Highlighting Global Leadership in Drug and Consumer Product Technologies\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        AptarGroup Inc. recently participated in the Jefferies Global Healthcare Conference, where CEO Stephan Tanda, CFO Vanessa Kanu, and SVP of Investor Relations &amp; Communications Mary Skafidas presented insights into the company's operations. AptarGroup is a global leader in drug and consumer product dosing, dispensing, and protection technologies, with significant contributions from its Pharma and Beauty segments, which account for 46% and 34% of total reported sales in 2024, respectively. The company's proprietary drug delivery systems provide a competitive advantage, supported by a robust innovation pipeline and a portfolio of over 7,000 active and pending patents. AptarGroup's global presence is bolstered by over 13,000 employees across 20 countries and a diverse customer base of over 5,000 global clients. You can access the full presentation through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AptarGroup Inc. published the original content used to generate this news brief on June 04, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4126","symbol_name":"金属与玻璃容器","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL5t5xCH:1","article_id":"2541179093","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2541179093","pubTimestamp":1749060532,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"AptarGroup Inc. recently participated in the Jefferies Global Healthcare Conference, where CEO Stephan Tanda, CFO Vanessa Kanu, and SVP of Investor Relations & Communications Mary Skafidas presented insights into the company's operations. AptarGroup is a global leader in drug and consumer product dosing, dispensing, and protection technologies, with significant contributions from its Pharma and Beauty segments, which account for 46% and 34% of total reported sales in 2024, respectively. The company's proprietary drug delivery systems provide a competitive advantage, supported by a robust innovation pipeline and a portfolio of over 7,000 active and pending patents. AptarGroup's global presence is bolstered by over 13,000 employees across 20 countries and a diverse customer base of over 5,000 global clients. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT striv","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4126":"金属与玻璃容器","ATR":"Aptar"},"translate_title":"AptarGroup Inc.发布演示文稿，强调药品和消费品技术领域的全球领导地位","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ATR":0.9},"content_text":"AptarGroup Inc. Unveils Presentation Highlighting Global Leadership in Drug and Consumer Product Technologies\n    \n\n        AptarGroup Inc. recently participated in the Jefferies Global Healthcare Conference, where CEO Stephan Tanda, CFO Vanessa Kanu, and SVP of Investor Relations & Communications Mary Skafidas presented insights into the company's operations. AptarGroup is a global leader in drug and consumer product dosing, dispensing, and protection technologies, with significant contributions from its Pharma and Beauty segments, which account for 46% and 34% of total reported sales in 2024, respectively. The company's proprietary drug delivery systems provide a competitive advantage, supported by a robust innovation pipeline and a portfolio of over 7,000 active and pending patents. AptarGroup's global presence is bolstered by over 13,000 employees across 20 countries and a diverse customer base of over 5,000 global clients. You can access the full presentation through the link below.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AptarGroup Inc. published the original content used to generate this news brief on June 04, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}